Clinical trial
Tenecteplase vs Medical Management in 4.5-24h Anterior Circulation Large Vessel Occlusion With no Access to EVT
NCT07168278 is registered in ClinicalTrials.gov with The First Affiliated Hospital of University of Science and Technology of China as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Tenecteplase vs Medical Management in 4.5-24h Anterior Circulation Large Vessel Occlusion With no Access to EVT
- Lead sponsor
- The First Affiliated Hospital of University of Science and Technology of China
- Phase
- Phase 3
- Overall status
- Not yet recruiting
- Start date
- November 1, 2025
- Completion date
- May 31, 2028
- Enrollment
- 794 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
acute ischemic stroke, large vessel occlusion, tenecteplase, thrombolysis